CompletedPhase 3

A Polysomnographic Study of Single-Dose Gabapentin in Transient Insomnia Induced by a Sleep Phase Advance

United States309 participantsStarted 2004-10

Plain-language summary

The purpose of this study is to assess the effect of gabapentin as compared to placebo on sleep in subjects with transient insomnia.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Aged \>/= 18 years * Females of child-bearing potential using medically-acceptable method of birth control \>/= 1 month prior to screening Exclusion Criteria: * Current or recent history (within 2 years) of sleep disorder (excessive snoring, obstructive sleep apnea, chronic painful condition) * Recreational drug use within past 30 days

What they're measuring

Latency to persistent sleep as measured by polysomnography

Timeframe: Hour +8

Trial details

NCT IDNCT00666770

SponsorPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

View on ClinicalTrials.gov More Transient Insomnia trials